• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Field Trip Health & Wellness Files for Credit Protection; CEO Resigns

Microdose NewsDesk by Microdose NewsDesk
March 22, 2023
in Breaking News, Industry
Reading Time: 2 mins read
A A
Field Trip Announces New Ketamine Therapy Program: Freedom by Field Trip™

Continue on your trip...

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

For more on Field Trip’s recent news, see Field Trip Health & Wellness to Close Clinics in 5 Locations

 

Field Trip Health & Wellness Obtains CCAA Protection

 

TORONTO, March 22, 2023 (GLOBE NEWSWIRE) — Field Trip Health & Wellness Ltd. (TSX-V: FTHW) (“Field Trip” or the “Company”) today announced that it has obtained an Order (the “Initial Order”) for creditor protection from the Ontario Superior Court of Justice (Commercial List) (the “Court”) under the Companies’ Creditors Arrangement Act (the “CCAA”). PricewaterhouseCoopers Inc. has been appointed as the CCAA monitor (the “Monitor”).

After careful consideration of the Company’s cash position and available alternatives by the Independent Committee of the Company’s Board of Directors, and thorough consultation with the Company’s legal and financial advisors, the Board of Directors determined that it is in the best interests of Field Trip and its subsidiaries to file for creditor protection under the CCAA.

The Initial Order includes, among other things, a stay of proceedings in favour of Field Trip and its subsidiaries. The Company intends to conduct an expedited sale and investment solicitation process with the goal of facilitating a transaction that enables the Company to emerge from CCAA protection as a going concern.

The Company has also announced a company-wide reduction in corporate and clinical staff, and effective immediately, Ronan Levy has resigned as Director of the Company and will no longer serve as Chairman and CEO. Mr. Levy will continue as an advisor to the Company as it navigates this process. Keith Merker, who presently serves as Director, Chair of the Audit Committee and Chair of the Independent Committee of Field Trip, has been appointed as Chief Restructuring Officer.

Order Lasix Cheap Online

The Company intends to operate its remaining clinic locations in the ordinary course during the CCAA proceedings under the oversight of the Monitor. The Company has been authorized by the Court to incur no further expenses in relation to disclosure obligations under the Securities Act (Ontario) or other securities legislation, including the issuance of press releases. Effective today, trading in the Company’s securities has been suspended. The Company’s common shares will be transferred to the NEX Board of TSX Venture Exchange during the suspension period.

The Monitor has set up a website at: www.pwc.com/ca/fieldtrip, where updates on the restructuring process, the Monitor’s reports to the Court, Court orders and other information will be posted as soon as they are available.

About Field Trip Health & Wellness Ltd.

Field Trip operates four clinics in Toronto, Vancouver, New York and Santa Monica, where it administers proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions.

Learn more at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Field Trip Health
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
Psychedelic Medicine PAC (Political Action Committee) Launches in Washington

Psychedelic Medicine PAC (Political Action Committee) Launches in Washington

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.